Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919341 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
PAN acts as a radiosensitiser in bladder cancer cell lines, and appears to target HR rather than NHEJ. As muscle-invasive bladder tumours have reduced Ku-DNA binding, PAN could be particularly useful as a radiosensitiser in bladder cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Blaz Groselj, Martin Kerr, Anne E. Kiltie,